EICHOR
● Completed
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
Condition: Acute Ischemic Stroke · Sponsor: Shionogi
About this study
The purpose of this study is to evaluate the efficacy and safety of redasemtide in adult participants with acute ischemic stroke (AIS). This study consists of 2 cohorts, Cohort A and Cohort B. Cohort A (redasemtide or placebo) will enroll participants who are ineligible for systemic thrombolysis and/or mechanical recanalization therapy. Cohort B (redasemtide or placebo) will enroll participants who are eligible to receive or who have received systemic thrombolysis and/or mechanical recanalization therapy as standard of care.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (150)
| Banner University of Arizona Medical Center | Tucson, Arizona, United States | — |
| Intercoastal Medical Group | Sarasota, Florida, United States | — |
| Augusta University | Augusta, Georgia, United States | — |
| Mercyhealth Javon Bea Hospital- Riverside | Rockford, Illinois, United States | — |
| Community Hospital | Munster, Indiana, United States | — |
| Sinai Hospital of Baltimore | Baltimore, Maryland, United States | — |
| Munson Healthcare | Traverse City, Michigan, United States | — |
| Mayo Clinic Hospital-Rochester, St. Mary's Campus - PPDS | Rochester, Minnesota, United States | — |
| North Shore University Hospital-300 Community Dr | Manhasset, New York, United States | — |
| Nuvance Health Medical Practice, PC- Neurosurgery | Poughkeepsie, New York, United States | — |
| Summa Health System - Akron Campus | Akron, Ohio, United States | — |
| Ohio State University Wexner Medical Center | Columbus, Ohio, United States | — |
+ 138 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05953480